Species Difference in the Metabolism of Mulberrin in Vitro and Its Inhibitory Effect on Cytochrome P450 and UDP-Glucuronosyltransferase Enzymes

被引:1
作者
Hu, Jiayin [1 ]
Hu, Tingting [1 ]
Guo, Zhe [1 ]
Song, Yonggui [2 ]
Shan, Lina [1 ]
Shi, Xianbao [1 ]
机构
[1] Jinzhou Med Univ, Affiliated Hosp 1, Jinzhou 121001, Peoples R China
[2] Jiangxi Univ Tradit Chinese Med, 1688 Meiling Rd, Nanchang 330006, Peoples R China
关键词
CYP; uridine 5'-diphosphate (UDP)-glucuronosyltransferase; liver microsome; interspecies dif-ference; mulberrin; Western blot analysis; DRUG-DRUG INTERACTIONS; HUMAN LIVER-MICROSOMES; HEPATIC-CLEARANCE; CANCER; GLUCURONIDATION; CYP3A4; UGT; IDENTIFICATION; CONSTITUENTS; PREVALENCE;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This study aimed to evaluate the interspecies difference in metabolism of mulberrin and examine the interaction between mulberrin and CYP enzymes or recombinant human uridine 5'-diphosphate (UDP)minipig (PLMs), monkey (MLMs), rabbit (RLMs), rat (RAMs), and mouse (MIMs) were used to investigate metabolic diversity among different species. Additionally, recombinant human supersomes were used to confirm that metabolic enzymes are involved in the biotransformation of mulberrin. We also evaluated the influence of mulberrin on protein expression by Western blot analysis. Mulberrin metabolism showed significant interspecies differences. We found four and two metabolites in phase I and II reaction systems, respectively. In phase I metabolism profiles of mulberrin for HLMs, PLMs and MLMs conformed to the classic Michaelis-Menten kinetics, RAMs and MIMs followed biphasic kinetics; phase II reaction of mulberrin in HLMs, DLMs, PLMs, MLMs, RLMs, RAMs and MIMs followed biphasic kinetics. UGT1A1 were the major CYP isoforms responsible for the metabolism of mulberrin. Mulberrin showed potent inhibitory effects against CYP3A4, CYP2C9, CYP2E1, UGT1A1, UGT1A3 and UGT2B7 with IC50 values of 54.21, 9.93, 39.12, 3.84, 2.01, 16.36 mu M, respectively. According to Western blot analysis, mulberrin can upregulate the protein expression of CYP2C19, and downregulate the expression levels of CYP3A5 and CYP2C9 in HepG2 cells as concentration increased. The interspecies comparisons can help find other species with metabolic pathways similar to those in humans for future in vivo studies.
引用
收藏
页码:669 / 678
页数:10
相关论文
共 56 条
  • [1] LC-MS/MS Estimation of Rociletinib Levels in Human Liver Microsomes: Application to Metabolic Stability Estimation
    Attwa, Mohamed
    Abdelhameed, Ali
    Kadi, Adnan
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 3915 - 3925
  • [2] Inhibition of human drug-metabolising cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in vitro by uremic toxins
    Barnes, Kyra J.
    Rowland, Andrew
    Polasek, Thomas M.
    Miners, John O.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70 (09) : 1097 - 1106
  • [3] Fatal adverse drug events: the paradox of drug treatment
    Buajordet, I
    Ebbesen, J
    Erikssen, J
    Brors, O
    Hilberg, T
    [J]. JOURNAL OF INTERNAL MEDICINE, 2001, 250 (04) : 327 - 341
  • [4] Mulberrin attenuates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson's disease by promoting Wnt/β-catenin signaling pathway
    Cao, Wenhui
    Dong, Yan
    Zhao, Weina
    Lu, Xin
    Sun, Li
    [J]. JOURNAL OF CHEMICAL NEUROANATOMY, 2019, 98 : 63 - 70
  • [5] Cryptotanshinone and dihydrotanshinone I exhibit strong inhibition towards human liver microsome (HLM)-catalyzed propofol glucuronidation
    Cong, Ming
    Hu, Cui-Min
    Cao, Yun-Feng
    Fang, Zhong-Ze
    Tang, Shu-Hong
    Wang, Jia-Rui
    Luo, Jun-Sheng
    [J]. FITOTERAPIA, 2013, 85 : 109 - 113
  • [6] On the use of the experimentally determined enzyme inhibition constant as a measure of absolute binding affinity
    Darras, Fouad H.
    Pang, Yuan-Ping
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 489 (04) : 451 - 454
  • [7] Inhibition of CYP3A4 and CYP3A5 expression by scutellarin is not mediated via the regulation of hsa-miR-27a, 27b, 148a, 298 and 451a levels
    Ding, Weiyao
    Cao, Change
    Gao, Yangyang
    Zhou, Xuan
    Lai, Yong
    [J]. XENOBIOTICA, 2020, 50 (11) : 1267 - 1274
  • [8] Substrate chirality and specificity of diacylglycerol kinases and the multisubstrate lipid kinase
    Epand, Richard M.
    Shulga, Yulia V.
    Timmons, Heath C.
    Perri, Alexandra L.
    Belani, Jitendra D.
    Perinpanathan, Kirishanth
    Johnson-McIntire, Laura Beth
    Bajjalieh, Sandra
    Dicu, Armela O.
    Elias, Cynthia
    Rychnovsky, Scott D.
    Topham, Matthew K.
    [J]. BIOCHEMISTRY, 2007, 46 (49) : 14225 - 14231
  • [9] The effect of valproic acid on drug and steroid glucuronidation by expressed human UDP-glucuronosyltransferases
    Ethell, BT
    Anderson, GD
    Burchell, B
    [J]. BIOCHEMICAL PHARMACOLOGY, 2003, 65 (09) : 1441 - 1449
  • [10] Time-dependent inhibition (TDI) of CYP3A4 and CYP2C9 by noscapine potentially explains clinical noscapine-warfarin interaction
    Fang, Zhong-Ze
    Zhang, Yan-Yan
    Ge, Guang-Bo
    Huo, Hong
    Liang, Si-Cheng
    Yang, Ling
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 69 (02) : 193 - 199